The aim of the pilot trial is to: 1. evaluate the potential effectiveness and effect size of the online self-management program for Rheumatoid Arthritis patients 2. to identify outcome measures most likely to capture potential patient benefit…
ID
Bron
Verkorte titel
Aandoening
Rheumatoid Arthritis
Ondersteuning
-Roche
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
We will use the following questionnaires:
<br><br>
The Patients Activation Measure (PAM-13) to measure self-management
<br><br>
The RAND-36 to measure health related quality of life
<br><br>
The Modified Pain Coping Inventory for Fatigue (MPCI-F) to measure coping with fatigue
<br><br>
The Rheumatoid Arthritis Self-Efficacy Scale (RASE) to measure task specific Self-efficacy
<br><br>
The Patient Efficacy in Patient-Physician Interactions (PEPPI-5) to measure patients'efficacy in obtaining medical information and attention to their medical concerns from physicians.
<br><br>
The Self-Management Ability Scale Short Form (SMAS-S) to measure self-management skills in relation to welfare.
<br><br>
NRS pain and NRS fatigue to measure the level of pain and fatigue of patients
Achtergrond van het onderzoek
Rationale: Rheumatoid Arthritis (RA) is a chronic inflammatory and systemic disease, which predominantly affects the joints. RA occurs in 0.5-1.0% of the adult population worldwide and two to four times more in women than in men. In the Netherlands approximately 150.000 people suffer from RA, making it the most common inflammatory joint disease. Because of
the large impact of RA on health status and healthcare expenditures, there is a growing interest in self-management for RA patients. However, while traditional delivery of selfmanagement support is effective overall, several problems in the development of e-delivered programs have led to variations in their effectiveness.
Objective: 1) To evaluate the potential effectiveness and effect size of the e-health selfmanagement support program for patients with RA. 2) To identify outcome measures most likely to capture potential patient benefit. 3) To evaluate continued participation or dropping out of the e-health intervention.
Study design: The intervention will be tested in an early randomized controlled trial with a six and twelve month follow-up from baseline.
Study population: Patients with RA and their healthcare professionals at the outpatient clinic of two hospitals in the Netherlands.
Intervention: On top of usual care the treatment group will receive a e-health selfmanagement program. The intervention consists of nine modules and strategies to support the behavioural change and behavioural maintenance of self-management behaviour.
Outcome: We will measure self-management behaviour (PAM-13), quality of life (RAND-36),
self-management skills (SMAS-S), coping with fatigue (using MPCIF),
Self-Efficacy (PEPPI-5 and RASE), pain and fatigue (NRS)
Doel van het onderzoek
The aim of the pilot trial is to:
1. evaluate the potential effectiveness and effect size of the online self-management program for Rheumatoid Arthritis patients
2. to identify outcome measures most likely to capture potential patient benefit;
3. to evaluate continued participation or dropping out of the online self-management program.
Onderzoeksopzet
Baseline data collection will start in December 2014. Repeated measures will be executed at six months and 12 months when the intervention is finished, again by filling out the questionnaire. The estimated time to fill out the questionnaire is 30 to 45 minutes.
Onderzoeksproduct en/of interventie
All participants in the study receive usual care containing regular visits to a rheumatologist
and a specialized nurse from whom they receive medical treatment, advice and information
about their disease and socio-psychological aspects. RA patients receive this care in a
structural way.
In addition to the care as usual, participants in the treatment group will receive the e-health
intervention. The intervention consists of nine modules:1) Finding balance between rest and
activity, 2) Setting boundaries, 3) Communication with professionals, 4) Coping with assistive
devices and home and household products, 5) Medication intake, 6) Coping with worries, 7)
Coping with RA, and 8) Coping with social support, 9) Performing physical activities.
Strategies to support the behavioural change and behavioural maintenance of selfmanagement
behaviour are: 1) providing information to increase patients’ knowledge, 2)
creating awareness by making assignments, 3) persuasive communication to change the
attitude of patients, 4) modelling through video’s and texts to increase patients’ self-efficacy,
5) social comparison through video’s and texts to increase patients’ self-efficacy, 6)
reinterpreting emotional and somatic state by texts to increase self-efficacy, 7) feedback and
planning coping response by text messages to maintain changed behaviour and 8) selfevaluation
through past temporal comparisons to maintain changed behaviour.
Publiek
Radboud universitair medisch centrum <br>
Postbus 9101, 6500 HB Nijmegen
R.M. Zuidema
Geert Grooteplein 21 (route 114)
Nijmegen
The Netherlands
(024) 36 55 607
rixt.zuidema@radboudumc.nl
Wetenschappelijk
Radboud universitair medisch centrum <br>
Postbus 9101, 6500 HB Nijmegen
R.M. Zuidema
Geert Grooteplein 21 (route 114)
Nijmegen
The Netherlands
(024) 36 55 607
rixt.zuidema@radboudumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- RA Patients;
- an age of 18 years or older;
- the ability to speak and read the Dutch language;
- the availability of a computer.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
-Patients receiving psychiatric and psychological treatment will be excluded.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL4726 |
NTR-old | NTR4871 |
Ander register | CMO : 2014-1208 |